A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
PedAL BCU, LLC
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Children's Oncology Group
Children's Hospital of Philadelphia